"Drug Delivery Systems" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.
| Descriptor ID |
D016503
|
| MeSH Number(s) |
E02.319.300
|
| Concept/Terms |
Drug Delivery Systems- Drug Delivery Systems
- Delivery System, Drug
- Delivery Systems, Drug
- Drug Delivery System
- System, Drug Delivery
- Systems, Drug Delivery
- Drug Targeting
- Drug Targetings
- Targeting, Drug
- Targetings, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Delivery Systems".
Below are MeSH descriptors whose meaning is more specific than "Drug Delivery Systems".
This graph shows the total number of publications written about "Drug Delivery Systems" by people in this website by year, and whether "Drug Delivery Systems" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 2 | 0 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 4 | 2 | 6 |
| 2003 | 2 | 1 | 3 |
| 2004 | 4 | 3 | 7 |
| 2005 | 4 | 0 | 4 |
| 2006 | 4 | 1 | 5 |
| 2007 | 4 | 3 | 7 |
| 2008 | 3 | 2 | 5 |
| 2009 | 6 | 4 | 10 |
| 2010 | 2 | 9 | 11 |
| 2011 | 6 | 5 | 11 |
| 2012 | 6 | 3 | 9 |
| 2013 | 7 | 3 | 10 |
| 2014 | 8 | 2 | 10 |
| 2015 | 5 | 2 | 7 |
| 2016 | 3 | 3 | 6 |
| 2017 | 4 | 6 | 10 |
| 2018 | 4 | 5 | 9 |
| 2019 | 1 | 1 | 2 |
| 2020 | 6 | 3 | 9 |
| 2021 | 1 | 8 | 9 |
| 2022 | 1 | 5 | 6 |
| 2023 | 1 | 7 | 8 |
| 2024 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Delivery Systems" by people in Profiles.
-
Wu K, Kwon SH, Zhou X, Fuller C, Wang X, Vadgama J, Wu Y. Overcoming Challenges in Small-Molecule Drug Bioavailability: A Review of Key Factors and Approaches. Int J Mol Sci. 2024 Dec 06; 25(23).
-
Gangavarapu A, Tapia-Lopez LV, Sarkar B, Pena-Zacarias J, Badruddoza AZM, Nurunnabi M. Lipid nanoparticles for enhancing oral bioavailability. Nanoscale. 2024 Oct 10; 16(39):18319-18338.
-
Mondal J, Chakraborty K, Bunggulawa EJ, An JM, Revuri V, Nurunnabi M, Lee YK. Recent advancements of hydrogels in immunotherapy: Breast cancer treatment. J Control Release. 2024 Aug; 372:1-30.
-
Bagde A, Mosley-Kellum K, Spencer S, Singh M. 3D DLP-printed cannabinoid microneedles patch and its pharmacokinetic evaluation in rats. J Pharm Pharmacol. 2024 Jun 06; 76(6):616-626.
-
Badruddoza AZM, Zahid MI, Walsh T, Shah J, Gates D, Yeoh T, Nurunnabi M. Topical drug delivery by Sepineo P600 emulgel: Relationship between rheology, physical stability, and formulation performance. Int J Pharm. 2024 Jun 10; 658:124210.
-
Diwan R, Gaytan SL, Bhatt HN, Pena-Zacarias J, Nurunnabi M. Liver fibrosis pathologies and potentials of RNA based therapeutics modalities. Drug Deliv Transl Res. 2024 Oct; 14(10):2743-2770.
-
Kumar R, Afrin H, Bhatt HN, Beaven E, Gangavarap A, Esquivel SV, Zahid MI, Nurunnabi M. Mucoadhesive Carrier-Mediated Oral Co-delivery of Bcl2 Inhibitors Improves Gastric Cancer Treatment. ACS Appl Mater Interfaces. 2024 Jan 10; 16(1):305-317.
-
Beaven E, Kumar R, An JM, Mendoza H, Sutradhar SC, Choi W, Narayan M, Lee YK, Nurunnabi M. Potentials of ionic liquids to overcome physical and biological barriers. Adv Drug Deliv Rev. 2024 01; 204:115157.
-
Adekiya TA, Owoseni O. Emerging frontiers in nanomedicine targeted therapy for prostate cancer. Cancer Treat Res Commun. 2023; 37:100778.
-
Annaji M, Mita N, Heard J, Kang X, Poudel I, Fasina O, Baskaran P, Boddu SHS, Tiwari AK, Chen P, Lyman CC, Babu RJ. 3D-Printed Capsaicin-Loaded Injectable Implants for Targeted Delivery in Obese Patients. AAPS PharmSciTech. 2023 Oct 02; 24(7):200.